The burden of disease associated with filaggrin mutations: A population-based, longitudinal birth cohort study

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 4, 2008, Pages

  Henderson, John ^a   Northstone, Kate ^a   Lee, Simon P ^b   Liao, Haihui ^c   Zhao, Yiwei ^c   Pembrey, Marcus ^d   Mukhopadhyay, Somnath ^b   Smith, George Davey ^a   Palmer, Colin N A ^b   McLean, W H Irwin ^c   Irvine, Alan D ^e  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c Epithelial Genetics Group   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

asthma; atopic dermatitis; atopy; birth cohort; Eczema; filaggrin; skin barrier

Indexed keywords

FILAGGRIN;

ARTICLE; ASTHMA; ATOPY; CAT; CONTROLLED STUDY; DANDER; DERMATOPHAGOIDES; ECZEMA; GENE MUTATION; GRASS; HUMAN; INFANT; MAJOR CLINICAL STUDY; NULL ALLELE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIZATION;

EID: 41449089071     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.01.026     Document Type: Article

References (20)

1. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006) 441-446
2. Marenholz I., Nickel R., Ruschendorf F., Schulz F., Esparza-Gordillo J., Kerscher T., et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 118 (2006) 866-871
3. Irvine A.D. Fleshing out filaggrin phenotypes. J Invest Dermatol 127 (2007) 504-507
4. Baurecht H., Irvine A.D., Novak N., Illig T., Buhler B., Ring J., et al. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 120 (2007) 1406-1412
5. Sandilands A., Terron-Kwiatkowski A., Hull P.R., O'Regan G.M., Clayton T.H., Watson R.M., et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39 (2007) 650-654
6. Golding J., Pembrey M., and Jones R. ALSPAC-the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatr Perinat Epidemiol 15 (2001) 74-87
7. Jones R.W., Ring S., Tyfield L., Hamvas R., Simmons H., Pembrey M., et al. A new human genetic resource: a DNA bank established as part of the Avon longitudinal study of pregnancy and childhood (ALSPAC). Eur J Hum Genet 8 (2000) 653-660
8. Johansson S.G., Bieber T., Dahl R., Friedmann P.S., Lanier B.Q., Lockey R.F., et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113 (2004) 832-836
9. Williams H.C., Burney P.G., Hay R.J., Archer C.B., Shipley M.J., Hunter J.J., et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 131 (1994) 383-396
10. Wadonda-Kabondo N., Sterne J.A., Golding J., Kennedy C.T., Archer C.B., and Dunnill M.G. A prospective study of the prevalence and incidence of atopic dermatitis in children aged 0-42 months. Br J Dermatol 149 (2003) 1023-1028
11. Asher M.I., Keil U., Anderson H.R., Beasley R., Crane J., Martinez F., et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 8 (1995) 483-491
12. Yan K., Salome C., and Woolcock A.J. Rapid method for measurement of bronchial responsiveness. Thorax 38 (1983) 760-765
13. Chinn S. Methodology of bronchial responsiveness. Thorax 53 (1998) 984-988
14. Candi E., Schmidt R., and Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6 (2005) 328-340
15. Irvine A.D., and McLean W.H. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 126 (2006) 1200-1202
16. Illi S., von Mutius E., Lau S., Nickel R., Gruber C., Niggemann B., et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 113 (2004) 925-931
17. Davey Smith G., and Ebrahim S. "Mendelian randomization": can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol 32 (2003) 1-22
18. He R., Oyoshi M.K., Jin H., and Geha R.S. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc Natl Acad Sci U S A 104 (2007) 15817-15822
19. Kondo H., Ichikawa Y., and Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 28 (1998) 769-779
20. Virtanen H., Remitz A., Malmberg P., Rytila P., Metso T., Haahtela T., et al. Topical tacrolimus in the treatment of atopic dermatitis-does it benefit the airways? A 4-year open follow-up. J Allergy Clin Immunol 120 (2007) 1464-1466